|
US6537579B1
(en)
*
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US20070116761A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
WO1999000113A1
(en)
*
|
1997-06-27 |
1999-01-07 |
Vivorx Pharmaceuticals, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20070092563A1
(en)
*
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
US8853260B2
(en)
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US7314637B1
(en)
|
1999-06-29 |
2008-01-01 |
Neopharm, Inc. |
Method of administering liposomal encapsulated taxane
|
|
US6040330A
(en)
*
|
1999-01-08 |
2000-03-21 |
Bionumerik Pharmaceuticals, Inc. |
Pharmaceutical formulations of taxanes
|
|
CA2371912C
(en)
*
|
1999-05-21 |
2010-02-16 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
GB9920548D0
(en)
*
|
1999-08-31 |
1999-11-03 |
Rhone Poulenc Rorer Sa |
Treatment of hepatocellular carcinoma
|
|
MXPA02008361A
(es)
|
2000-02-28 |
2004-05-17 |
Genesegues Inc |
Sistema y metodo de encapsulacion de nanocapsulas.
|
|
US7473433B2
(en)
|
2000-12-21 |
2009-01-06 |
Nektar Therapeutics |
Pulmonary delivery of polyene antifungal agents
|
|
ITMI20001107A1
(it)
*
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
|
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US6977085B2
(en)
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US6607784B2
(en)
|
2000-12-22 |
2003-08-19 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
KR100426636B1
(ko)
*
|
2001-05-18 |
2004-04-08 |
한국과학기술연구원 |
주사 가능한 젤 상의 조성물 및 그의 제조방법
|
|
MXPA04002446A
(es)
*
|
2001-09-26 |
2004-07-23 |
Baxter Int |
Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
|
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
WO2003032906A2
(en)
|
2001-10-15 |
2003-04-24 |
Crititech, Inc. |
Delivery of poorly soluble drugs
|
|
US7112340B2
(en)
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
ITMI20020681A1
(it)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina
|
|
ITMI20020680A1
(it)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Composizione antitumorale migliorata a base di paclitaxel e metodo per il suo ottenimento
|
|
US20030207907A1
(en)
|
2002-05-03 |
2003-11-06 |
Iversen Patrick L. |
Delivery of microparticle-conjugated drugs for inhibition of stenosis
|
|
ITMI20021392A1
(it)
*
|
2002-06-25 |
2003-12-29 |
Nicox Sa |
Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
|
|
PL206379B1
(pl)
|
2002-07-15 |
2010-08-31 |
Alcon |
Ulegająca bioerozji kompozycja do wytwarzania błony do dostarczania leków oftalmicznych i zastosowanie
|
|
GB0216700D0
(en)
|
2002-07-18 |
2002-08-28 |
Astrazeneca Ab |
Process
|
|
IL150906A0
(en)
*
|
2002-07-25 |
2003-02-12 |
Yissum Res Dev Co |
Diagnostic microspheres
|
|
DE10234784A1
(de)
*
|
2002-07-30 |
2004-02-19 |
Günenthal GmbH |
Intravenös applizierbare, pharmazeutische Darreichungsform
|
|
US7838034B2
(en)
|
2002-07-30 |
2010-11-23 |
Grunenthal Gmbh |
Intravenous pharmaceutical form of administration
|
|
DK1585548T3
(en)
|
2002-12-09 |
2018-09-03 |
Abraxis Bioscience Llc |
COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS
|
|
KR100871529B1
(ko)
*
|
2002-12-09 |
2008-12-05 |
치아-시앙 수 |
정맥내 주사용으로 적합한 피브리노겐 입자의 제조방법
|
|
EA200501252A1
(ru)
|
2003-02-03 |
2006-02-24 |
Неофарм, Инк. |
Липосомальная композиция, способ ее получения и лекарственное средство на ее основе (варианты)
|
|
GB0302673D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
|
CN1303994C
(zh)
*
|
2003-03-03 |
2007-03-14 |
浙江海正药业股份有限公司 |
紫杉醇囊泡注射剂及其制备方法
|
|
US8476010B2
(en)
|
2003-07-10 |
2013-07-02 |
App Pharmaceuticals Llc |
Propofol formulations with non-reactive container closures
|
|
DE602005025606D1
(de)
|
2004-01-21 |
2011-02-10 |
Univ London Pharmacy |
Verfahren zur herstellung von mikroteilchen
|
|
KR100578382B1
(ko)
|
2004-07-16 |
2006-05-11 |
나재운 |
항암제의 전달체용 수용성 키토산 나노입자 및 그 제조방법
|
|
CN103169729A
(zh)
|
2005-02-18 |
2013-06-26 |
阿布拉科斯生物科学有限公司 |
治疗剂的组合和给予方式以及联合治疗
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
US20090028950A1
(en)
*
|
2005-06-29 |
2009-01-29 |
Mitsubishi Chemical Corporation |
Granule dispersion composition, process for producing the same, and granular material and medicine
|
|
US7771751B2
(en)
|
2005-08-31 |
2010-08-10 |
Abraxis Bioscience, Llc |
Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
|
|
CN101291658B
(zh)
*
|
2005-08-31 |
2014-04-16 |
阿布拉科斯生物科学有限公司 |
用于制备稳定性增加的水难溶性药物的组合物和方法
|
|
KR20080080087A
(ko)
*
|
2005-09-30 |
2008-09-02 |
티티아이 엘뷰 가부시키가이샤 |
신규 약학 담체를 이용한 경피 약물 전달시스템, 장치 및방법
|
|
EA015781B1
(ru)
*
|
2005-10-21 |
2011-12-30 |
Панацея Биотек Лимитед |
Композиции для лечения рака
|
|
JP5368300B2
(ja)
*
|
2006-06-08 |
2013-12-18 |
スリーエム イノベイティブ プロパティズ カンパニー |
ポリマービーズおよびポリマービーズの製造方法
|
|
US20080181947A1
(en)
|
2006-09-26 |
2008-07-31 |
Astellas Pharma Inc. |
Controlled release dosage form of tacrolimus
|
|
US9675578B2
(en)
|
2006-12-14 |
2017-06-13 |
Abraxis Bioscience, Llc |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
|
WO2008084698A1
(ja)
|
2006-12-28 |
2008-07-17 |
Astellas Pharma Inc. |
タクロリムス徐放性医薬組成物
|
|
EP3417859A1
(en)
|
2007-03-07 |
2018-12-26 |
Abraxis BioScience, LLC |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
WO2008137148A2
(en)
|
2007-05-03 |
2008-11-13 |
Abraxis Bioscience, Llc |
Methods and compositions for treating pulmonary hypertension
|
|
AU2008260447B2
(en)
|
2007-06-01 |
2013-10-10 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
|
WO2009097570A2
(en)
*
|
2008-01-30 |
2009-08-06 |
University Of Kansas |
Intralymphatic chemotherapy drug carriers
|
|
RU2496482C2
(ru)
|
2008-03-05 |
2013-10-27 |
Бакстер Интернэшнл Инк. |
Композиции и способы для доставки лекарственных средств
|
|
CA2721153C
(en)
*
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
WO2009126175A1
(en)
*
|
2008-04-10 |
2009-10-15 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
EP3266453A1
(en)
|
2008-07-03 |
2018-01-10 |
Mayo Foundation for Medical Education and Research |
Treating cancer
|
|
KR101043407B1
(ko)
*
|
2009-02-19 |
2011-06-22 |
한국과학기술연구원 |
암 표적성이 우수한 단백질 복합체 및 이의 제조방법
|
|
KR101066197B1
(ko)
|
2009-04-06 |
2011-09-20 |
한국생명공학연구원 |
코엔자임 ｑ10 나노입자, 그 제조방법 및 상기 나노입자를 포함하는 조성물
|
|
MX2011010673A
(es)
*
|
2009-04-10 |
2012-02-21 |
Abraxis Bioscience Llc |
Formulaciones de nanoparticulas y usos de las mismas.
|
|
HRP20192259T1
(hr)
|
2009-04-15 |
2020-03-06 |
Abraxis Bioscience, Llc |
Pripravci nanočestica bez priona i metode njihove proizvodnje
|
|
BR112012004149A2
(pt)
*
|
2009-08-25 |
2016-03-22 |
Abraxis Bioscience Llc |
terapia de combinação com composições de nanopartículas de taxano e inibidores de hedgehog
|
|
JP4856752B2
(ja)
*
|
2009-11-30 |
2012-01-18 |
ホソカワミクロン株式会社 |
薬物含有ナノ粒子の製造方法
|
|
US9629920B2
(en)
|
2009-12-18 |
2017-04-25 |
Exodos Life Sciences Limited Partnership |
Methods and compositions for stable liquid drug formulations
|
|
US9333189B2
(en)
*
|
2010-02-03 |
2016-05-10 |
Oncbiomune, Inc. |
Taxane- and taxoid-protein compositions
|
|
CA3051495A1
(en)
|
2010-03-26 |
2011-09-29 |
Abraxis Bioscience, Llc |
Use of nanoparticles comprising a taxane and albumin in the treatment of hepatocellular carcinoma
|
|
US9393318B2
(en)
|
2010-03-29 |
2016-07-19 |
Abraxis Bioscience, Llc |
Methods of treating cancer
|
|
KR20130028727A
(ko)
|
2010-03-29 |
2013-03-19 |
아브락시스 바이오사이언스, 엘엘씨 |
치료제의 약물 전달 및 유효성 향상 방법
|
|
JP5824511B2
(ja)
|
2010-05-03 |
2015-11-25 |
テイコク ファーマ ユーエスエー インコーポレーテッド |
非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
|
|
KR20130088116A
(ko)
|
2010-06-04 |
2013-08-07 |
아브락시스 바이오사이언스, 엘엘씨 |
췌장암의 치료 방법
|
|
CA2801891C
(en)
*
|
2010-06-07 |
2020-10-27 |
Abraxis Bioscience, Llc |
Combination therapy methods for treating proliferative diseases
|
|
KR101007948B1
(ko)
|
2010-08-13 |
2011-01-14 |
김지훈 |
스팀을 이용한 고무 블록의 성형 방법
|
|
WO2012051220A1
(en)
*
|
2010-10-11 |
2012-04-19 |
Wichita State University |
Composite magnetic nanoparticle drug delivery system
|
|
CN102670518B
(zh)
*
|
2011-03-14 |
2014-08-20 |
齐鲁制药有限公司 |
一种难溶性药物球形颗粒的制备方法
|
|
ME03589B
(me)
|
2011-04-01 |
2020-07-20 |
Astrazeneca Ab |
Terapeutski tretman
|
|
HUE048876T2
(hu)
|
2011-05-09 |
2020-08-28 |
Mayo Found Medical Education & Res |
Rákos megbetegedések kezelése
|
|
MX367640B
(es)
|
2011-11-30 |
2019-08-29 |
Astrazeneca Ab |
Tratamiento combinado del cáncer.
|
|
PL2790675T3
(pl)
|
2011-12-14 |
2019-12-31 |
Abraxis Bioscience, Llc |
Zastosowanie polimerowych rozczynników do liofilizacji lub zamrażania cząstek
|
|
WO2013115559A1
(ko)
*
|
2012-01-30 |
2013-08-08 |
성균관대학교 산학협력단 |
수난용성 약물을 내부에 포함하는 알부민 나노입자 제조방법
|
|
EP2833905B1
(en)
|
2012-04-04 |
2018-05-02 |
Halozyme, Inc. |
Combination therapy with hyaluronidase and a tumor-targeted taxane
|
|
AU2013204533B2
(en)
|
2012-04-17 |
2017-02-02 |
Astrazeneca Ab |
Crystalline forms
|
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
|
US10413606B2
(en)
|
2012-10-01 |
2019-09-17 |
Mayo Foundation For Medical Education And Research |
Methods for treating cancer with nanoparticle complexes of albumin-bound paclitaxel and anti-VEGF antibodies
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
US20150352050A1
(en)
*
|
2012-11-15 |
2015-12-10 |
Utah-Inha Dds & Advanced Therapeutics Research Center |
Biodegradable microbeads with improved anticancer drug adsorptivity, containing albumin and dextran sulfate, and preparation method therefor
|
|
US9999676B2
(en)
|
2012-11-27 |
2018-06-19 |
Utah-Inha Dds & Advanced Therapeutics Research Center |
Biodegradable microbead comprising anionic polymer for improving adsorptive power to anticancer drugs, and method for preparing same
|
|
CN103908432B
(zh)
*
|
2013-01-02 |
2018-09-21 |
博瑞生物医药（苏州）股份有限公司 |
一种伊沙匹隆白蛋白的冻干组合物及其制备方法
|
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
CA2900136C
(en)
|
2013-03-04 |
2021-05-04 |
Astrazeneca Ab |
Combination treatment
|
|
JP6349381B2
(ja)
|
2013-03-12 |
2018-06-27 |
アブラクシス バイオサイエンス， エルエルシー |
肺がんを処置する方法
|
|
JP6309610B2
(ja)
|
2013-03-14 |
2018-04-11 |
アブラクシス バイオサイエンス， エルエルシー |
膀胱がんを処置する方法
|
|
KR101329646B1
(ko)
|
2013-05-02 |
2013-11-14 |
주식회사 지니스 |
표적지향증폭형 항암나노입자 및 이의 제조방법
|
|
IL228528A
(en)
|
2013-09-17 |
2015-01-29 |
Technion Res & Dev Foundation |
Potato-based nanoparticles
|
|
WO2015051349A1
(en)
*
|
2013-10-04 |
2015-04-09 |
Sorrento Therapeutics, Inc. |
Treating metastatic cancer with micellular paclitaxel
|
|
CN104758942A
(zh)
*
|
2014-01-02 |
2015-07-08 |
国家纳米科学中心 |
基于蛋白质的药理活性物质组合物及其制备方法和应用
|
|
WO2015152433A1
(en)
|
2014-03-31 |
2015-10-08 |
Hanmi Pharm. Co., Ltd. |
Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same
|
|
WO2015187194A1
(en)
*
|
2014-06-01 |
2015-12-10 |
Crititech, Inc. |
Use of paclitaxel particles
|
|
US20150352176A1
(en)
*
|
2014-06-06 |
2015-12-10 |
Newport Research, Inc. |
Oil-free and fat-free aqueous suspensions of cyclosporin
|
|
EP3154586B1
(en)
|
2014-06-13 |
2020-05-27 |
Mayo Foundation for Medical Education and Research |
Treating lymphomas
|
|
US10213513B2
(en)
|
2014-06-16 |
2019-02-26 |
Mayo Foundation For Medical Education And Research |
Treating myelomas
|
|
SG10201902499VA
(en)
|
2014-09-03 |
2019-04-29 |
Genesegues Inc |
Therapeutic nanoparticles and related compositions, methods and systems
|
|
CN107073132B
(zh)
|
2014-10-06 |
2021-08-27 |
梅约医学教育与研究基金会 |
载体-抗体组合物及其制备和使用方法
|
|
US11324800B2
(en)
|
2015-01-15 |
2022-05-10 |
Wellspring Ophthalmics, Inc. |
Aqueous suspensions of cyclosporin
|
|
US20200237859A1
(en)
|
2019-01-25 |
2020-07-30 |
Newport Research, Inc. |
Aqueous suspensions of cyclosporin
|
|
US10527604B1
(en)
|
2015-03-05 |
2020-01-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
|
|
US10705070B1
(en)
|
2015-03-05 |
2020-07-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
|
|
JP6758325B2
(ja)
|
2015-06-04 |
2020-09-23 |
クリティテック・インコーポレイテッド |
タキサン粒子およびその使用
|
|
SMT202100642T1
(it)
|
2015-06-29 |
2022-03-21 |
Abraxis Bioscience Llc |
Nanoparticelle comprendenti sirolimus e un'albumina per l'uso nel trattamento di tumori a cellule epitelioidi
|
|
TW201707725A
(zh)
|
2015-08-18 |
2017-03-01 |
美國馬友醫藥教育研究基金會 |
載體－抗體組合物及其製造及使用方法
|
|
CN114588270B
(zh)
|
2015-09-16 |
2024-08-06 |
Dfb索里亚有限责任公司 |
包含紫杉烷类纳米颗粒的组合物及其用途
|
|
TW201713360A
(en)
|
2015-10-06 |
2017-04-16 |
Mayo Foundation |
Methods of treating cancer using compositions of antibodies and carrier proteins
|
|
CN105412024B
(zh)
*
|
2015-12-14 |
2018-03-30 |
广州帝奇医药技术有限公司 |
靶向疏水性抗肿瘤药物纳米制剂及其制备方法
|
|
WO2017120501A1
(en)
|
2016-01-07 |
2017-07-13 |
Mayo Foundation For Medical Education And Research |
Methods of treating cancer with interferon
|
|
JP6953414B2
(ja)
*
|
2016-01-20 |
2021-10-27 |
フラリー パウダーズ エルエルシーＦｌｕｒｒｙ Ｐｏｗｄｅｒｓ，Ｌｌｃ |
親油性成分を含む吸入に好適な分散性の噴霧乾燥粉末を製造する方法
|
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
|
US11351254B2
(en)
|
2016-02-12 |
2022-06-07 |
Mayo Foundation For Medical Education And Research |
Hematologic cancer treatments
|
|
WO2017165440A1
(en)
|
2016-03-21 |
2017-09-28 |
Mayo Foundation For Medical Education And Research |
Methods for reducing toxicity of a chemotherapeutic drug
|
|
EP3432928A4
(en)
|
2016-03-21 |
2019-11-20 |
Mayo Foundation for Medical Education and Research |
PROCESS FOR IMPROVING THE THERAPEUTIC INDEX FOR CHEMOTHERAPEUTIC
|
|
CN114767860A
(zh)
|
2016-04-04 |
2022-07-22 |
克里蒂泰克公司 |
实体肿瘤治疗方法
|
|
US10618969B2
(en)
|
2016-04-06 |
2020-04-14 |
Mayo Foundation For Medical Education And Research |
Carrier-binding agent compositions and methods of making and using the same
|
|
CN105944109B
(zh)
*
|
2016-05-03 |
2019-06-11 |
四川大学 |
一种肾小球靶向的蛋白纳米颗粒药物组合物及其用途
|
|
TWI771315B
(zh)
*
|
2016-08-26 |
2022-07-21 |
奧野哲治 |
微小奈米化藥劑及其利用
|
|
CN109890419A
(zh)
|
2016-09-01 |
2019-06-14 |
梅约医学教育与研究基金会 |
用于治疗癌症的载体-pd-l1结合剂组合物
|
|
CN109843336A
(zh)
|
2016-09-01 |
2019-06-04 |
梅约医学教育与研究基金会 |
用于靶向t细胞癌症的方法和组合物
|
|
AU2017324947A1
(en)
|
2016-09-06 |
2019-03-28 |
Mayo Foundation For Medical Education And Research |
Paclitaxel-albumin-binding agent compositions and methods for using and making the same
|
|
US11590098B2
(en)
|
2016-09-06 |
2023-02-28 |
Mayo Foundation For Medical Education And Research |
Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
|
|
CN109843924A
(zh)
|
2016-09-06 |
2019-06-04 |
梅约医学教育与研究基金会 |
治疗表达pd-l1的癌症的方法
|
|
WO2018071399A1
(en)
*
|
2016-10-10 |
2018-04-19 |
Abraxis Bioscience, Llc |
Nanoparticle formulations and methods of making and using thereof
|
|
WO2018170196A1
(en)
|
2017-03-15 |
2018-09-20 |
Dfb Soria, Llc |
Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
|
|
CA3063420A1
(en)
|
2017-06-09 |
2018-12-13 |
Crititech, Inc. |
Treatment of epithelial cysts by intracystic injection of antineoplastic particles
|
|
AU2018284247B2
(en)
|
2017-06-14 |
2020-04-30 |
Crititech Inc. |
Methods for treating lung disorders
|
|
US20200170992A1
(en)
*
|
2017-07-07 |
2020-06-04 |
Dfb Pharmaceuticals, Llc |
Treatment of hyperplastic tissue growths including benign prostatic hyperplasia (bph) by direct injection of an antineoplastic agent
|
|
CN107510600A
(zh)
*
|
2017-08-07 |
2017-12-26 |
苏州大学 |
一种制备药用固体微粒的设备及方法
|
|
CA3076919A1
(en)
|
2017-10-03 |
2019-04-11 |
Crititech, Inc. |
Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
|
|
US11819488B2
(en)
|
2018-02-23 |
2023-11-21 |
Rhnanopharma |
Nanosuspensions of salsalate and methods of using the same
|
|
US11497726B2
(en)
|
2018-03-16 |
2022-11-15 |
Dfb Soria, Ll. |
Topical therapy for the treatment of cervical intraepithelial neoplasia (CIN) and cervical cancer using nanoparticles of taxanes
|
|
AU2019239953B2
(en)
|
2018-03-20 |
2025-01-02 |
Abraxis Bioscience, Llc |
Methods of treating central nervous system disorders via administration of nanoparticles of an mtor inhibitor and an albumin
|
|
JP7256824B2
(ja)
*
|
2018-04-25 |
2023-04-12 |
エスリス ゲーエムベーハー |
粒子状製剤用の凍結保護剤
|
|
WO2019222435A1
(en)
|
2018-05-16 |
2019-11-21 |
Halozyme, Inc. |
Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
|
|
US20220257521A1
(en)
*
|
2019-06-14 |
2022-08-18 |
Folium Biosciences Europe B.V. |
Method for micro-encapsulation of natural ingredients by means of contacting with supercritical gas
|
|
IL292439B2
(en)
|
2019-10-28 |
2026-05-01 |
Abraxis Bioscience Llc |
Pharmaceutical preparations of albumin and rapamycin
|
|
JP7874161B2
(ja)
*
|
2021-10-14 |
2026-06-15 |
スカイ・セラピューティクス・カンパニー・リミテッド |
有機物、無機物またはこれらの塩からなるナノ分子会合体及びその製造方法
|
|
KR102526793B1
(ko)
*
|
2021-11-03 |
2023-04-28 |
주식회사 에스엔바이오사이언스 |
입도분포 유지 안정성이 개선된 알부민 결합 탁산 나노입자 제조방법
|
|
CN116672300A
(zh)
*
|
2022-02-23 |
2023-09-01 |
苏州博创同康医药科技有限公司 |
一种载药纤维材料及其制备方法和用途
|
|
US20250213523A1
(en)
|
2022-04-05 |
2025-07-03 |
Istituto Nazionale Tumori Irccs - Fondazione G. Pascale |
Combination of hdac inhibitors and statins for use in the treatment of pancreatic cancer
|
|
EP4501320A1
(en)
*
|
2023-08-02 |
2025-02-05 |
IQ medical GmbH |
A method of preparing an aqueous dispersion of nanoparticles
|
|
KR102683810B1
(ko)
*
|
2024-03-26 |
2024-07-11 |
큐어라벨 주식회사 |
글루타치온, 아스코빅애씨드 및 항산화 활성을 가지는 유용성 생리활성물질을 포함하는 나노 입자의 제조방법 및 이를 함유하는 화장료 조성물
|